Literature DB >> 24823684

The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database.

Atsuhiko Murata1, Kohji Okamoto, Toshihiko Mayumi, Keiji Muramatsu, Shinya Matsuda.   

Abstract

The aim of this study is to investigate the recent trend over time of outcomes of patients with disseminated intravascular coagulation (DIC) based on the Japanese administrative database. A total of 34,711 patients with DIC had been referred to 1,092 hospitals from 2010 to 2012 in Japan. We collected patients' data from the administrative database to compare in-hospital mortality within 14 and 28 days between periods. The study periods were categorized into three groups: 2010 (n = 8,382), 2011 (n = 13,372), and 2012 (n = 12,957). These analyses were performed according to the underlying diseases associated with DIC. The in-hospital mortality within 14 or 28 days of DIC patients with infectious diseases decreased between 2010 and 2012 (within 14 days: 20.4 vs. 18.1 vs. 17.9 %, P = 0.009; within 28 days: 31.1 vs. 28.7 vs. 27.7%, P = 0.003; respectively). Multiple logistic regressions also showed that the period was associated with in-hospital mortality of DIC patients with infectious diseases. The odds ratios of 2011 and 2012 for in-hospital mortality within 14 days were 0.86 [95% confidence intervals (CI) 0.77-0.97] and 0.84 (95% CI 0.75-0.94) whereas those for in-hospital mortality within 28 days were 0.89 (95% CI 0.81-0.98) and 0.83 (95% CI 0.76-0.92), respectively. However, there were no significant differences in mortality of patients with DIC associated with other underlying diseases between 2010 and 2012. This study demonstrated that in-hospital mortality of DIC patients with infectious diseases gradually improved between 2010 and 2012 in Japan.

Entities:  

Mesh:

Year:  2014        PMID: 24823684     DOI: 10.1007/s11239-014-1068-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  36 in total

1.  Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients.

Authors:  Satoshi Gando; Hideo Wada; Hidesaku Asakura; Toshiaki Iba; Yutaka Eguchi; Kohji Okamoto; Yasuhiro Ohtomo; Kazuo Kawasugi; Shin Koga; Kazuhide Koseki; Hajime Tsuji; Toshihiko Mayumi; Atsuo Murata; Masao Nakagawa; Shigeatu Endo
Journal:  Clin Appl Thromb Hemost       Date:  2005-01       Impact factor: 2.389

2.  Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study.

Authors:  Lene Frost Andersen; David R Jacobs; Monica H Carlsen; Rune Blomhoff
Journal:  Am J Clin Nutr       Date:  2006-05       Impact factor: 7.045

3.  Modified score for disseminated intravascular coagulation in the critically ill.

Authors:  Mirka Sivula; Minna Tallgren; Ville Pettilä
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

Review 4.  Disseminated intravascular coagulation: a review for the internist.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intern Emerg Med       Date:  2012-09-27       Impact factor: 3.397

5.  New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores.

Authors:  Matthias W A Angstwurm; Carl-Erik Dempfle; Michael Spannagl
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

6.  Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.

Authors:  K Okajima; Y Sakamoto; M Uchiba
Journal:  Am J Hematol       Date:  2000-11       Impact factor: 10.047

7.  Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

Authors:  J Kienast; M Juers; C J Wiedermann; J N Hoffmann; H Ostermann; R Strauss; H-O Keinecke; B L Warren; S M Opal
Journal:  J Thromb Haemost       Date:  2006-01       Impact factor: 5.824

8.  Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.

Authors:  Atsushi Sawamura; Satoshi Gando; Mineji Hayakawa; Hirokatsu Hoshino; Nobuhiko Kubota; Masahiro Sugano
Journal:  Clin Appl Thromb Hemost       Date:  2008-10-07       Impact factor: 2.389

9.  Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Authors:  Giampiero Mazzaglia; Ettore Ambrosioni; Marianna Alacqua; Alessandro Filippi; Emiliano Sessa; Vincenzo Immordino; Claudio Borghi; Ovidio Brignoli; Achille P Caputi; Claudio Cricelli; Lorenzo G Mantovani
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

10.  Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.

Authors:  Kazuma Yamakawa; Hiroshi Ogura; Satoshi Fujimi; Miki Morikawa; Yoshihito Ogawa; Tomoyoshi Mohri; Yasushi Nakamori; Yoshiaki Inoue; Yasuyuki Kuwagata; Hiroshi Tanaka; Toshimitsu Hamasaki; Takeshi Shimazu
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

View more
  9 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Effect of hospital volume on outcomes of laparoscopic appendectomy for acute appendicitis: an observational study.

Authors:  Atsuhiko Murata; Toshihiko Mayumi; Keiji Muramatsu; Makoto Ohtani; Shinya Matsuda
Journal:  J Gastrointest Surg       Date:  2015-01-17       Impact factor: 3.452

3.  Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation.

Authors:  Atsuhiko Murata; Kohji Okamoto; Toshihiko Mayumi; Keiji Muramatsu; Shinya Matsuda
Journal:  Int J Clin Pharm       Date:  2014-12-17

4.  Time Trends of the Outcomes and Treatment Options for Disseminated Intravascular Coagulation: A Nationwide Observational Study in Japan.

Authors:  Kazuma Yamakawa; Hiroyuki Ohbe; Kohei Taniguchi; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  JMA J       Date:  2020-09-23

Review 5.  Sepsis and disseminated intravascular coagulation.

Authors:  Kohji Okamoto; Toshihisa Tamura; Yusuke Sawatsubashi
Journal:  J Intensive Care       Date:  2016-03-23

6.  Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.

Authors:  Kenichiro Nogami; Isao Muraki; Hironori Imano; Hiroyasu Iso
Journal:  BMJ Open       Date:  2017-01-25       Impact factor: 2.692

7.  Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.

Authors:  Kohei Taniguchi; Hiroyuki Ohbe; Kazuma Yamakawa; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

8.  Comparison of Procedure-Based and Diagnosis-Based Identifications of Severe Sepsis and Disseminated Intravascular Coagulation in Administrative Data.

Authors:  Hayato Yamana; Hiromasa Horiguchi; Kiyohide Fushimi; Hideo Yasunaga
Journal:  J Epidemiol       Date:  2016-04-09       Impact factor: 3.211

9.  Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.

Authors:  Takuhiro Yamaguchi; Yukio Kitajima; Yasuhiro Miyauchi; Kazutoshi Izawa; Masakazu Tanaka; Masatada Hirata; Yasunari Sadatsuki; Yoshihiro Ogawa
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.